Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03912064
Brief Title: A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT

First Submitted : April 10, 2019
First Submitted that Met QC Criteria : April 10, 2019
First Posted : April 11, 2019

Last Update Submitted that Met QC Criteria : July 22, 2019
Last Update Posted : July 23, 2019